Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Atara Biotherapeutics Inc Annual Shareholders Meeting Transcript

Jun 16, 2020 / 04:00PM GMT
Release Date Price: $263.5 (+0.86%)
Operator

Welcome to the Annual Meeting of Stockholders of Atara Biotherapeutics. Your host will be Pascal Touchon, President and Chief Executive Officer of Atara Biotherapeutics.

Pascal, you may now begin.

Pascal Touchon
Atara Biotherapeutics, Inc. - President, CEO & Director

Good morning. This is Pascal Touchon, President and Chief Executive Officer and a member of the Board of Atara Biotherapeutics. I'm very happy to welcome you to the Atara Biotherapeutics 2020 Annual Meeting of Stockholders.

Before I call the meeting to order, I would like to introduce to you the members of the Board and the members of the business team who are with us today via teleconference. The members of the Board with us virtually today are: Ron Renaud, Chair of the Board; Roy Baynes; Eric Dobmeier; Matthew Fust; Carol Gallagher; Bill Heiden; Maria Grazia Roncarolo; and Beth Seidenberg.

The officers of the company with us virtually today are Utpal Koppikar, Chief Financial Officer; Kristin Yarema, Chief Commercial Officer; Jakob Dupont, Global Head of Research

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot